164 related articles for article (PubMed ID: 3546420)
41. Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis.
Gold MH; Olin JT
Expert Rev Anti Infect Ther; 2015; 13(12):1433-40. PubMed ID: 26559086
[TBL] [Abstract][Full Text] [Related]
42. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis.
Elewski BE; Jones T; Zaias N
Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432
[TBL] [Abstract][Full Text] [Related]
43. Topical treatment of tinea pedis using 6% coriander oil in unguentum leniens: a randomized, controlled, comparative pilot study.
Beikert FC; Anastasiadou Z; Fritzen B; Frank U; Augustin M
Dermatology; 2013; 226(1):47-51. PubMed ID: 23466353
[TBL] [Abstract][Full Text] [Related]
44. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
Bergstresser PR; Elewski B; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
J Am Acad Dermatol; 1993 Apr; 28(4):648-51. PubMed ID: 8463471
[No Abstract] [Full Text] [Related]
45. Efficacy and safety of short-term itraconazole in tinea pedis: a double-blind, randomized, placebo-controlled trial.
Svejgaard E; Avnstorp C; Wanscher B; Nilsson J; Heremans A
Dermatology; 1998; 197(4):368-72. PubMed ID: 9873176
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of Tinea Pedis in Elderly Patients Using External Preparations].
Otani M
Med Mycol J; 2017; 58(2):J35-J41. PubMed ID: 28566665
[TBL] [Abstract][Full Text] [Related]
47. Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Stengel F; Robles-Soto M; Galimberti R; Suchil P
Int J Dermatol; 1994 Oct; 33(10):726-9. PubMed ID: 8002145
[No Abstract] [Full Text] [Related]
48. Topical griseofulvin in the treatment of dermatophytoses.
Aly R; Bayles CI; Oakes RA; Bibel DJ; Maibach HI
Clin Exp Dermatol; 1994 Jan; 19(1):43-6. PubMed ID: 8313635
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
50. A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis.
Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
Mycoses; 2006 May; 49(3):236-41. PubMed ID: 16681817
[TBL] [Abstract][Full Text] [Related]
51. Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum.
White JE; Perkins PJ; Evans EG
Br J Dermatol; 1991 Sep; 125(3):260-2. PubMed ID: 1911319
[TBL] [Abstract][Full Text] [Related]
52. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
[TBL] [Abstract][Full Text] [Related]
53. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
Brown M; Evans C; Muddle A; Turner R; Lim S; Reed J; Traynor M
Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
[TBL] [Abstract][Full Text] [Related]
54. Comparison between undecylenic acid and tolnaftate in the treatment of tinea pedis.
Fuerst JF; Cox GF; Weaver SM; Duncan WC
Cutis; 1980 May; 25(5):544-6, 549. PubMed ID: 6991217
[TBL] [Abstract][Full Text] [Related]
55. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
Korting HC; Kiencke P; Nelles S; Rychlik R
Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
Gupta AK; Skinner AR; Cooper EA
Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients.
Sinha SD; Rajamma A; Bandi MR; Sriramadasu SC; Sahu S; Kothiwala RK; Halder S; Sankerneni A; Panapakam M; Vemireddy VNR; Vattipalli R; Devireddy SR
Clin Drug Investig; 2023 Jul; 43(7):565-574. PubMed ID: 37462803
[TBL] [Abstract][Full Text] [Related]
58. Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma.
Stashower ME
Cutis; 2006 Jul; 78(1):66-9. PubMed ID: 16903324
[TBL] [Abstract][Full Text] [Related]
59. [Treatment of interdigital tinea pedis].
Korting HC; Rychlik R; Pfeil B
Dtsch Med Wochenschr; 2003 Sep; 128(36):1819-24. PubMed ID: 12964099
[TBL] [Abstract][Full Text] [Related]
60. Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine.
Savin RC
J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):786-9. PubMed ID: 2229524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
